The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
A new type of immunotherapy that targets non-cancer cells could help prevent the growth and spread of breast cancer tumours, according to new research funded by Breast Cancer Now.
Researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme.
Cancer research is driving progress in treatment that means more and more people are living well for longer after a diagnosis of advanced cancer. In our latest blog post, hear from five people who are each responding well to treatment and are now looking to the future, after receiving a devastating diagnosis.
Ceralasertib showed promise for patients no longer responding to current cancer treatments in an early clinical trial. Given on its own, the drug stabilised the growth of tumours in more than half of patients who received it, with one patient seeing benefits for more than five years
Our research is made possible by our generous community of donors and supporters. Help transform the lives of people with cancer.
We aim to attract the best scientific minds who will be working at the forefront of cancer research, in an environment that’s collaborative, international and inclusive.
We draw upon our excellent scientists and facilities to further our world-class cancer research. We work with funders to deliver major research centres and collaborations.
Our competitive PhD programme is designed for the next generation of world-leading cancer researchers who will benefit from exceptional research facilities.
We are internationally renowned for driving scientific discoveries on cancer and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
We have made huge strides in research and treatment for children with cancer, improving their chances of survival. With your support today, we can discover kinder treatments and offer more children the hope of a cure.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
We always want to hear from people who have a cancer story to share.
Get in touch and help raise awareness of our research.
The ICR-CTSU leads high-quality international cancer clinical trials, and their findings directly influence clinical practice within the NHS and worldwide.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
To really save the lives of children with brain cancer, we need to minimise morbidity
Making a better home for our microbes – the relationship between the microbiome and disease, including cancer